Cargando…
pyCancerSig: subclassifying human cancer with comprehensive single nucleotide, structural and microsatellite mutational signature deconstruction from whole genome sequencing
BACKGROUND: DNA damage accumulates over the course of cancer development. The often-substantial amount of somatic mutations in cancer poses a challenge to traditional methods to characterize tumors based on driver mutations. However, advances in machine learning technology can take advantage of this...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118897/ https://www.ncbi.nlm.nih.gov/pubmed/32245405 http://dx.doi.org/10.1186/s12859-020-3451-8 |
_version_ | 1783514659337273344 |
---|---|
author | Thutkawkorapin, Jessada Eisfeldt, Jesper Tham, Emma Nilsson, Daniel |
author_facet | Thutkawkorapin, Jessada Eisfeldt, Jesper Tham, Emma Nilsson, Daniel |
author_sort | Thutkawkorapin, Jessada |
collection | PubMed |
description | BACKGROUND: DNA damage accumulates over the course of cancer development. The often-substantial amount of somatic mutations in cancer poses a challenge to traditional methods to characterize tumors based on driver mutations. However, advances in machine learning technology can take advantage of this substantial amount of data. RESULTS: We developed a command line interface python package, pyCancerSig, to perform sample profiling by integrating single nucleotide variation (SNV), structural variation (SV) and microsatellite instability (MSI) profiles into a unified profile. It also provides a command to decipher underlying cancer processes, employing an unsupervised learning technique, Non-negative Matrix Factorization, and a command to visualize the results. The package accepts common standard file formats (vcf, bam). The program was evaluated using a cohort of breast- and colorectal cancer from The Cancer Genome Atlas project (TCGA). The result showed that by integrating multiple mutations modes, the tool can correctly identify cases with known clear mutational signatures and can strengthen signatures in cases with unclear signal from an SNV-only profile. The software package is available at https://github.com/jessada/pyCancerSig. CONCLUSIONS: pyCancerSig has demonstrated its capability in identifying known and unknown cancer processes, and at the same time, illuminates the association within and between the mutation modes. |
format | Online Article Text |
id | pubmed-7118897 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-71188972020-04-07 pyCancerSig: subclassifying human cancer with comprehensive single nucleotide, structural and microsatellite mutational signature deconstruction from whole genome sequencing Thutkawkorapin, Jessada Eisfeldt, Jesper Tham, Emma Nilsson, Daniel BMC Bioinformatics Software BACKGROUND: DNA damage accumulates over the course of cancer development. The often-substantial amount of somatic mutations in cancer poses a challenge to traditional methods to characterize tumors based on driver mutations. However, advances in machine learning technology can take advantage of this substantial amount of data. RESULTS: We developed a command line interface python package, pyCancerSig, to perform sample profiling by integrating single nucleotide variation (SNV), structural variation (SV) and microsatellite instability (MSI) profiles into a unified profile. It also provides a command to decipher underlying cancer processes, employing an unsupervised learning technique, Non-negative Matrix Factorization, and a command to visualize the results. The package accepts common standard file formats (vcf, bam). The program was evaluated using a cohort of breast- and colorectal cancer from The Cancer Genome Atlas project (TCGA). The result showed that by integrating multiple mutations modes, the tool can correctly identify cases with known clear mutational signatures and can strengthen signatures in cases with unclear signal from an SNV-only profile. The software package is available at https://github.com/jessada/pyCancerSig. CONCLUSIONS: pyCancerSig has demonstrated its capability in identifying known and unknown cancer processes, and at the same time, illuminates the association within and between the mutation modes. BioMed Central 2020-04-03 /pmc/articles/PMC7118897/ /pubmed/32245405 http://dx.doi.org/10.1186/s12859-020-3451-8 Text en © The Author(s). 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Software Thutkawkorapin, Jessada Eisfeldt, Jesper Tham, Emma Nilsson, Daniel pyCancerSig: subclassifying human cancer with comprehensive single nucleotide, structural and microsatellite mutational signature deconstruction from whole genome sequencing |
title | pyCancerSig: subclassifying human cancer with comprehensive single nucleotide, structural and microsatellite mutational signature deconstruction from whole genome sequencing |
title_full | pyCancerSig: subclassifying human cancer with comprehensive single nucleotide, structural and microsatellite mutational signature deconstruction from whole genome sequencing |
title_fullStr | pyCancerSig: subclassifying human cancer with comprehensive single nucleotide, structural and microsatellite mutational signature deconstruction from whole genome sequencing |
title_full_unstemmed | pyCancerSig: subclassifying human cancer with comprehensive single nucleotide, structural and microsatellite mutational signature deconstruction from whole genome sequencing |
title_short | pyCancerSig: subclassifying human cancer with comprehensive single nucleotide, structural and microsatellite mutational signature deconstruction from whole genome sequencing |
title_sort | pycancersig: subclassifying human cancer with comprehensive single nucleotide, structural and microsatellite mutational signature deconstruction from whole genome sequencing |
topic | Software |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118897/ https://www.ncbi.nlm.nih.gov/pubmed/32245405 http://dx.doi.org/10.1186/s12859-020-3451-8 |
work_keys_str_mv | AT thutkawkorapinjessada pycancersigsubclassifyinghumancancerwithcomprehensivesinglenucleotidestructuralandmicrosatellitemutationalsignaturedeconstructionfromwholegenomesequencing AT eisfeldtjesper pycancersigsubclassifyinghumancancerwithcomprehensivesinglenucleotidestructuralandmicrosatellitemutationalsignaturedeconstructionfromwholegenomesequencing AT thamemma pycancersigsubclassifyinghumancancerwithcomprehensivesinglenucleotidestructuralandmicrosatellitemutationalsignaturedeconstructionfromwholegenomesequencing AT nilssondaniel pycancersigsubclassifyinghumancancerwithcomprehensivesinglenucleotidestructuralandmicrosatellitemutationalsignaturedeconstructionfromwholegenomesequencing |